Orchestra BioMed Holdings Inc. (OBIO) — Long-term Investment Intensity

Latest as of December 2025: 2.2%

Orchestra BioMed Holdings Inc. (OBIO) has a Long-term Investment Intensity of 2.2% as of December 2025. Long-term investments of $2.50 Million represent 2.2% of total assets of $114.86 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Orchestra BioMed Holdings Inc. asset resilience ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

2.2%
LT Investments / Total Assets

Long-term Investments

$2.50 Million
USD

Total Assets

$114.86 Million
USD

Country

USA
NASDAQ

Orchestra BioMed Holdings Inc. Long-term Investment Intensity (2020–2025)

This chart shows how Orchestra BioMed Holdings Inc.'s Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the intensity stands at 2.2%, reflecting long-term investments of $2.50 Million against total assets of $114.86 Million USD. For the complete balance sheet picture, see Orchestra BioMed Holdings Inc. total assets.

Annual Long-term Investment Intensity for Orchestra BioMed Holdings Inc. (2020–2025)

The table below presents the year-by-year Long-term Investment Intensity for Orchestra BioMed Holdings Inc. from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read OBIO total debt and obligations for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 2.2% $2.50 Million $114.86 Million ▼ -1.1 pp
2024 3.3% $2.50 Million $76.17 Million ▲ +0.7 pp
2023 2.6% $2.50 Million $95.21 Million ▲ +0.0 pp
2022 2.6% $2.50 Million $95.57 Million ▼ -0.3 pp
2021 2.9% $398.00K $13.53 Million ▲ +2.5 pp
2020 0.5% $185.00K $38.09 Million —
pp = percentage points